315 related articles for article (PubMed ID: 27599779)
1. Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma.
Matsumoto Y; Kano M; Akutsu Y; Hanari N; Hoshino I; Murakami K; Usui A; Suito H; Takahashi M; Otsuka R; Xin H; Komatsu A; Iida K; Matsubara H
Oncol Rep; 2016 Nov; 36(5):2535-2543. PubMed ID: 27599779
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma.
Tanaka Y; Kamohara H; Kinoshita K; Kurashige J; Ishimoto T; Iwatsuki M; Watanabe M; Baba H
Cancer; 2013 Mar; 119(6):1159-67. PubMed ID: 23224754
[TBL] [Abstract][Full Text] [Related]
3. Five-lncRNA signature in plasma exosomes serves as diagnostic biomarker for esophageal squamous cell carcinoma.
Jiao Z; Yu A; Rong W; He X; Zen K; Shi M; Wang T
Aging (Albany NY); 2020 Jun; 12(14):15002-15010. PubMed ID: 32597791
[TBL] [Abstract][Full Text] [Related]
4. Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival.
Xing S; Zheng X; Zeng T; Zeng MS; Zhong Q; Cao YS; Pan KL; Wei C; Hou F; Liu WL
World J Gastroenterol; 2017 Nov; 23(43):7693-7704. PubMed ID: 29209110
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of circulating exosomes-based liquid biopsy for esophageal cancer.
Zhao A; Guo L; Xu J; Zheng L; Guo Z; Ling Z; Wang L; Mao W
Cancer Med; 2019 Jul; 8(7):3566-3574. PubMed ID: 31099496
[TBL] [Abstract][Full Text] [Related]
6. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.
Cui Y; Xue Y; Dong S; Zhang P
J Int Med Res; 2017 Aug; 45(4):1310-1317. PubMed ID: 28587538
[TBL] [Abstract][Full Text] [Related]
7. Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE.
Jing R; Chen W; Wang H; Ju S; Cong H; Sun B; Jin Q; Chu S; Xu L; Cui M
Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G719-29. PubMed ID: 26316588
[TBL] [Abstract][Full Text] [Related]
8. Plasma miRNA-506 as a Prognostic Biomarker for Esophageal Squamous Cell Carcinoma.
Li SP; Su HX; Zhao D; Guan QL
Med Sci Monit; 2016 Jun; 22():2195-201. PubMed ID: 27345473
[TBL] [Abstract][Full Text] [Related]
9. Proteomic profiling of plasma exosomes reveals CD82 involvement in the development of esophageal squamous cell carcinoma.
Yang L; Salai A; Sun X; Liu Q; Liu T; Zhang Q; Tuerxun A; Tan Y; Zheng S; Lu X
J Proteomics; 2022 Aug; 265():104662. PubMed ID: 35728771
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of function and clinical potential of exosomes in esophageal squamous cell carcinoma.
Zhao L; Yu L; Wang X; He J; Zhu X; Zhang R; Yang A
Cancer Lett; 2023 Jan; 553():215993. PubMed ID: 36328162
[TBL] [Abstract][Full Text] [Related]
11. Plasma microRNA-19a as a potential biomarker for esophageal squamous cell carcinoma diagnosis and prognosis.
Bai Y; Lin H; Fang Z; Luo Q; Fang Y; Su Y; Hu Q; Duan H; Chen F; Zhang ZY
Biomark Med; 2017 May; 11(5):431-441. PubMed ID: 28621611
[TBL] [Abstract][Full Text] [Related]
12. Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy.
Wang XB; Jiang XR; Yu XY; Wang L; He S; Feng FY; Guo LP; Jiang W; Lu SH
Cancer Sci; 2014 Feb; 105(2):176-85. PubMed ID: 24383865
[TBL] [Abstract][Full Text] [Related]
13. Serum microRNA-15a level acts as a potential diagnostic and prognostic biomarker for human esophageal squamous cell carcinoma.
Li J; Li M; Gao F; Ge X
Cancer Biomark; 2017; 18(1):11-17. PubMed ID: 27802201
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen promotes malignant biological tumor behavior involving epithelial-mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma.
Zhang F; Wang Y; Sun P; Wang ZQ; Wang DS; Zhang DS; Wang FH; Fu JH; Xu RH; Li YH
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2413-2424. PubMed ID: 28801734
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma.
Sun J; Song K; Feng X; Gao S
Biochem Biophys Res Commun; 2016 Apr; 473(2):363-9. PubMed ID: 26777997
[TBL] [Abstract][Full Text] [Related]
16. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
Liu Z; Yang T; Xu Z; Cao X
Biomed Pharmacother; 2016 Aug; 82():406-12. PubMed ID: 27470379
[TBL] [Abstract][Full Text] [Related]
18. Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA.
Kang M; Ren M; Li Y; Fu Y; Deng M; Li C
J Exp Clin Cancer Res; 2018 Jul; 37(1):171. PubMed ID: 30049286
[TBL] [Abstract][Full Text] [Related]
19. Exosome-derived miR-200a promotes esophageal cancer cell proliferation and migration via the mediating Keap1 expression.
Li P; Liu X; Xing W; Qiu H; Li R; Liu S; Sun H
Mol Cell Biochem; 2022 Apr; 477(4):1295-1308. PubMed ID: 35137328
[TBL] [Abstract][Full Text] [Related]
20. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]